Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Ovarian Neoplasms 8Breast Neoplasms 8Carcinoma, Ovarian Epithelial 4Carcinoma, Non-Small-Cell Lung 4Fallopian Tube Neoplasms 3Endometrial Neoplasms 3Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Esophageal Squamous Cell Carcinoma 2Carcinoma 2Uterine Neoplasms 1Urologic Neoplasms 1Urogenital Neoplasms 1Unresectable Stage III NSCLC 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thrombocytopenia 1Primary Breast Cancer 1Pharyngeal Neoplasms 1Penile Neoplasms 1Pathologic Complete Response 1Paranasal Sinus Neoplasms 1Ovarian Diseases 1Neutropenia 1Neoplasms, Unknown Primary 1Neoplasms, Glandular and Epithelial 1Neoplasms by Site 1Neoplasms by Histologic Type 1Neoplasms 1Neoplasm Metastasis 1

Interventions

Filgrastim 7pegylated granulocyte colony-stimulating factor 5pegfilgrastim 5Cytarabine 4Ciprofloxacin 4Cefepime 4Vancomycin 3Leucovorin 3Fluorouracil 3Amikacin 3trifluridine tipiracil drug combination 2Piperacillin, Tazobactam Drug Combination 2Methylprednisolone 2Meropenem 2Irinotecan 2Etoposide 2Daptomycin 2Cisplatin 2Ceftazidime 2ziprasidone 1trilaciclib 1sargramostim 1niraparib 1liposomal amphotericin B 1lintuzumab 1leridistim 1isavuconazole 1fludarabine phosphate 1flt3 ligand protein 1fish oil triglycerides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neutropenia × CP protocol × Clear all
NCT05963334 2023-07-27

Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer

Cairo University

Phase 1/2 Completed
49 enrolled
Classical hematology

Anemia, Neutropenia, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡